US2003170281A1PendingUtilityA1

Cosmetic and dermatological preparations based on O/W emulsions

Assignee: BEIERSDORF AGPriority: Jul 26, 1999Filed: Feb 19, 2003Published: Sep 11, 2003
Est. expiryJul 26, 2019(expired)· nominal 20-yr term from priority
A61K 8/375A61Q 19/00A61K 8/361A61K 8/06A61K 8/39A61K 8/062
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Stable, biocompatible cosmetic or dermatological oil-in-water emulsions (I), containing fatty acids and alcohols, glycerides, ethoxylated esters, non-polar lipids and consistency components, are disclosed. Cosmetic or dermatological oil-in-water emulsion preparations (I) contain (by weight): (a) 0.1-5% 14-22C fatty acid(s); (b) 0.1-10% fatty acid mono- and/or diglyceride(s); (c) 0.1-5% ethoxylated fatty acid ester(s); (d) 0.5-10% non-polar lipid(s); (e) 0.5-7.5% fatty alcohol(s); and (f) 0.5-7.5% lipophilic consistency source(s) having a melting point or drop point of at least 30 degrees C. The sum of the contents of (a)-(c) is at most 12% by weight based on the total weight of the emulsion and the lipid phase optionally contains up to 40% by weight (based on this phase) of polar lipids.

Claims

exact text as granted — not AI-modified
1 . Cosmetic and dermatological preparations in the form of O/W emulsions, comprising 
 (1) 0.1 up to 5% by weight, based on the total weight of the preparations, of one or more C 14 -C 22 -fatty acids,    (2) 0.2 up to 10% by weight, based on the total weight of the preparations, of one or more mono- and/or diglycerides of fatty acids,    (3) 0.1 up to 5% by weight, based on the total weight of the preparations, of one or more ethoxylated fatty acid esters,    where the sum of (1), (2) and (3) is at most 12% by weight,    (4) 0.5 to 10% by weight, based on the total weight of the preparations, of one or more nonpolar lipids,    (5) 0.5-7.5% by weight, based on the total weight of the preparations, of one or more fatty alcohols    (6) 0.5-7.5% by weight, based on the total weight of the preparations, of one or more lipophilic bodying agents having a melting point or dropping point of ≧30° C.    (7) where the total lipid phase can comprise up to 40% by weight of polar lipids, based on the total weight of the lipid phase.    
     
     
         2 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (1) 0.5 up to 1.0% by weight, based on the total weight of the preparations, of one or more C 14 -C 22 -fatty acids.    
     
     
         3 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (2) 2.5 up to 3.0% by weight, based on the total weight of the preparations, of one or more mono- and/or diglycerides of fatty acids.    
     
     
         4 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (3) 1.0 up to 1.5% by weight, based on the total weight of the preparations, of one or more ethoxylated fatty acid esters.    
     
     
         5 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (2) up to 10% by weight, based on the total weight of the preparations, of glyceryl stearate.    
     
     
         6 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (3) up to 5% by weight, based on the total weight of the preparations, of one or more ethoxylated fatty acid esters chosen from the group of PEG-20 to PEG-100 stearates.    
     
     
         7 . Cosmetic or dermatological preparations according to  claim 1 , comprising 
 (5) 0.5 to 10% by weight, based on the total weight of the preparations, of one or more nonpolar lipids, chosen from the group of mineral oil and/or mineral waxes (including Vaseline).    
     
     
         8 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (6) 2.0-3.0% by weight, based on the total weight of the preparations, of one or more fatty alcohols.    
     
     
         9 . Cosmetic and dermatological preparations according to  claim 1 , comprising 
 (7) 1.5-2.5% by weight, based on the total weight of the preparations, of one or more lipophilic bodying agents having a melting point or dropping point of ≧30° C.

Join the waitlist — get patent alerts

Track US2003170281A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.